Original Research
Published on 14 Mar 2024
CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder
in Respiratory Pharmacology
- 2,081 views
- 1 citation